Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080449802> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W3080449802 endingPage "9" @default.
- W3080449802 startingPage "1" @default.
- W3080449802 abstract "Cardiovascular disease (CVD) is the leading cause of death worldwide and one key factor associated with the increased CVD risk is dyslipidemia. Statin therapy remains the first-line treatment to manage dyslipidemia, yet many patients do not achieve optimal low-density lipoprotein-cholesterol (LDL-C) levels even after taking moderate- or high-intensity statins; therefore, additional, non-statin therapy is often needed. Bempedoic acid is a prodrug that, once activated, decreases LDL-C levels by the inhibition of adenosine triphosphate citrate lyase in the liver. Five clinical trials have demonstrated the safety and efficacy of bempedoic acid and the bempedoic acid/ezetimibe combination in lowering LDL-C in patients with atherosclerotic CVD and heterozygous familial hypercholesterolemia and also in high-risk primary prevention, and statin-intolerant patients. Bempedoic acid has been demonstrated to lower LDL-C levels by 15-25% in clinical trials and up to 38% when combined with ezetimibe. In 2020, the FDA approved bempedoic acid. Furthermore, the combination of bempedoic acid with ezetimibe is FDA approved for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic CVD who require additional LDL-C lowering after maximally tolerated statin therapy. The ongoing CLEAR OUTCOMES trial aims to evaluate whether bempedoic acid can reduce cardiovascular events in patients with statin intolerance and results will be available in the next 3 years. This outcomes trial will be pivotal for determining the role of bempedoic acid in the non-statin lipid-lowering armamentarium." @default.
- W3080449802 created "2020-09-01" @default.
- W3080449802 creator A5027067847 @default.
- W3080449802 creator A5032630989 @default.
- W3080449802 date "2020-08-24" @default.
- W3080449802 modified "2023-10-01" @default.
- W3080449802 title "Bempedoic acid for the treatment of dyslipidemia" @default.
- W3080449802 cites W1520609538 @default.
- W3080449802 cites W201469966 @default.
- W3080449802 cites W2065191931 @default.
- W3080449802 cites W2093391254 @default.
- W3080449802 cites W2117644277 @default.
- W3080449802 cites W2118184073 @default.
- W3080449802 cites W2230299152 @default.
- W3080449802 cites W2333497995 @default.
- W3080449802 cites W2519634482 @default.
- W3080449802 cites W2521647868 @default.
- W3080449802 cites W2584841803 @default.
- W3080449802 cites W2596179513 @default.
- W3080449802 cites W2800876320 @default.
- W3080449802 cites W2808641584 @default.
- W3080449802 cites W2899997727 @default.
- W3080449802 cites W2900034165 @default.
- W3080449802 cites W2915308926 @default.
- W3080449802 cites W2922038538 @default.
- W3080449802 cites W2928534885 @default.
- W3080449802 cites W2965327853 @default.
- W3080449802 cites W2987850771 @default.
- W3080449802 cites W3003299879 @default.
- W3080449802 cites W3040223903 @default.
- W3080449802 cites W3129818723 @default.
- W3080449802 cites W867395513 @default.
- W3080449802 doi "https://doi.org/10.7573/dic.2020-6-5" @default.
- W3080449802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7449648" @default.
- W3080449802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32922503" @default.
- W3080449802 hasPublicationYear "2020" @default.
- W3080449802 type Work @default.
- W3080449802 sameAs 3080449802 @default.
- W3080449802 citedByCount "17" @default.
- W3080449802 countsByYear W30804498022021 @default.
- W3080449802 countsByYear W30804498022022 @default.
- W3080449802 countsByYear W30804498022023 @default.
- W3080449802 crossrefType "journal-article" @default.
- W3080449802 hasAuthorship W3080449802A5027067847 @default.
- W3080449802 hasAuthorship W3080449802A5032630989 @default.
- W3080449802 hasBestOaLocation W30804498021 @default.
- W3080449802 hasConcept C126322002 @default.
- W3080449802 hasConcept C134018914 @default.
- W3080449802 hasConcept C2776839432 @default.
- W3080449802 hasConcept C2776999253 @default.
- W3080449802 hasConcept C2778096610 @default.
- W3080449802 hasConcept C2778163477 @default.
- W3080449802 hasConcept C2778657065 @default.
- W3080449802 hasConcept C2779120738 @default.
- W3080449802 hasConcept C2779134260 @default.
- W3080449802 hasConcept C535046627 @default.
- W3080449802 hasConcept C71924100 @default.
- W3080449802 hasConcept C90924648 @default.
- W3080449802 hasConceptScore W3080449802C126322002 @default.
- W3080449802 hasConceptScore W3080449802C134018914 @default.
- W3080449802 hasConceptScore W3080449802C2776839432 @default.
- W3080449802 hasConceptScore W3080449802C2776999253 @default.
- W3080449802 hasConceptScore W3080449802C2778096610 @default.
- W3080449802 hasConceptScore W3080449802C2778163477 @default.
- W3080449802 hasConceptScore W3080449802C2778657065 @default.
- W3080449802 hasConceptScore W3080449802C2779120738 @default.
- W3080449802 hasConceptScore W3080449802C2779134260 @default.
- W3080449802 hasConceptScore W3080449802C535046627 @default.
- W3080449802 hasConceptScore W3080449802C71924100 @default.
- W3080449802 hasConceptScore W3080449802C90924648 @default.
- W3080449802 hasLocation W30804498021 @default.
- W3080449802 hasLocation W30804498022 @default.
- W3080449802 hasLocation W30804498023 @default.
- W3080449802 hasLocation W30804498024 @default.
- W3080449802 hasOpenAccess W3080449802 @default.
- W3080449802 hasPrimaryLocation W30804498021 @default.
- W3080449802 hasRelatedWork W1977220205 @default.
- W3080449802 hasRelatedWork W2034095303 @default.
- W3080449802 hasRelatedWork W2045521574 @default.
- W3080449802 hasRelatedWork W2408722788 @default.
- W3080449802 hasRelatedWork W3128812232 @default.
- W3080449802 hasRelatedWork W3168743993 @default.
- W3080449802 hasRelatedWork W3198702738 @default.
- W3080449802 hasRelatedWork W4288766474 @default.
- W3080449802 hasRelatedWork W4376135456 @default.
- W3080449802 hasRelatedWork W4377019136 @default.
- W3080449802 hasVolume "9" @default.
- W3080449802 isParatext "false" @default.
- W3080449802 isRetracted "false" @default.
- W3080449802 magId "3080449802" @default.
- W3080449802 workType "article" @default.